Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2002

01-05-2002 | Conference Report

One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

Authors: Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan GM Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine MA Tilanus, Carina CM Bartels, Leon C Verhoog, Cecile TM Brekelmans, Curt W Burger, Martinus F Niermeijer

Published in: Breast Cancer Research and Treatment | Issue 2/2002

Login to get access
Metadata
Title
One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)
Authors
Litanja N Lodder
Petra G Frets
R Willem Trijsburg
E Johanna Meijers-Heijboer
Jan GM Klijn
Caroline Seynaeve
Albertus N van Geel
Madeleine MA Tilanus
Carina CM Bartels
Leon C Verhoog
Cecile TM Brekelmans
Curt W Burger
Martinus F Niermeijer
Publication date
01-05-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1015269620265

Other articles of this Issue 2/2002

Breast Cancer Research and Treatment 2/2002 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine